Medical Information

Elmiro is a medication used to treat interstitial cystitis/bladder pain syndrome, and its efficacy and discontinuation precautions need to be evaluated in conjunction with clinical trials. The following will explain from two aspects: treatment effect and precautions for stopping medication.

1. Therapeutic effect

(1) Relieve symptoms

Aibuluo can improve pain, frequent urination, and urgency symptoms in patients with interstitial cystitis, with about 30-40% of patients experiencing significant relief after 3-6 months of medication.

(2) Effective time

The medication needs to be continuously used for at least 3 months to evaluate its efficacy, and some patients may need more than 6 months to observe significant effects.

(3) Differences in therapeutic efficacy

Individual reactions vary greatly, with about 40% of patients possibly showing no significant response to treatment, and alternative therapies need to be considered.

2. Precautions for discontinuation of medication

(1) Gradually reduce

Long term users are advised to gradually reduce and stop taking medication to avoid symptom relapse. The dosage can be reduced by 25% every 2-4 weeks, and the recommended total reduction period is 2-3 months.

(2) Indications for discontinuation of medication

When serious adverse reactions such as liver dysfunction, bleeding tendency, or visual changes occur, the medication should be stopped immediately and medical evaluation should be sought.

(3) Follow up monitoring

Regular follow-up is still necessary after discontinuation of medication to monitor symptom recurrence and potential delayed adverse reactions.

(4) Alternative therapy

If symptoms recur after discontinuing medication, it is necessary to discuss other treatment options with a doctor, such as bladder instillation or physical therapy.